BrainChild Bio Raises $116 Million in Series A Financing

Gunderson Dettmer has advised BrainChild Bio. BrainChild Bio, a clinical-stage biotechnology company, has announced the closure of a $116 million Series A financing round. The financing…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here